Pivotal bioVenture Partners Fund I, L.P.

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Robert Hopfner - for Pivotal bioVenture Partners Fund I, L.P., By: Robert Hopfner, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pivotal bioVenture Partners Fund I, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inozyme Pharma, Inc. Director Common Stock 1,571,741 $5,611,115 $3.57 01 Aug 2023 Indirect
Evommune, Inc. Director, 10%+ Owner Common Stock 294,502 07 Nov 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series A Preferred Stock 0 07 Nov 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series B Preferred Stock 0 07 Nov 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 07 Nov 2025 Indirect
Evommune, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 07 Nov 2025 Indirect

Insider Reports Filed by Pivotal bioVenture Partners Fund I, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000101297525000730-pivotal-bioventure-partners-fund-i-l-p-2025-11-07 Evommune, Inc. 07 Nov 2025 12 $0 4 Director, 10%+ Owner 12 Nov 2025, 16:46
/report/000101297525000705-pivotal-bioventure-partners-fund-i-l-p-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Director, 10%+ Owner 05 Nov 2025, 20:11
INZY Inozyme Pharma, Inc. 01 Aug 2023 2 +$3,999,998 4 Director 03 Aug 2023, 20:13
INZY Inozyme Pharma, Inc. 19 Apr 2022 1 +$3,948,300 4 Director 20 Apr 2022, 18:22